RyR2 / TRP channels
Name: Ryanodine receptor 2
(RyR2)
Official Symbol: RYR2
provided by HGNC
Function:
Calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytoplasm and thereby plays a key role in triggering cardiac muscle contraction. Aberrant channel activation can lead to cardiac arrhythmia. In cardiac myocytes, calcium release is triggered by increased Ca(2+) levels due to activation of the L-type calcium channel CACNA1C. The calcium channel activity is modulated by formation of heterotetramers with RYR3. Required for cellular calcium ion homeostasis. Required for embryonic heart development.
Source: Reorganizing the protein space at the Universal Protein Resource (UniProt)
Nucleic Acids Res. 40: D71-D75 (2012).
Species | External DB | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Entrez Gene | UniprotKB | DIP | IntAct | MINT | BioGRID | STRING | IUPHAR-DB | KEGG | OMIM | |
Human
|
6262 | Q92736 | DIP-38325N | Q92736 | MINT-1201008 | 112174 | Q92736 | hsa:6262 | 180902 | |
Mouse
|
20191 | Q9ERN6 | DIP-32244N | Q9ERN6 | MINT-4129173 | 203046 | Q9ERN6 | mmu:20191 | ||
Rat
|
689560 | B0LPN4 | UNK-5492549 | 604379 | B0LPN4 | rno:689560 |
Biological Process:
- GO:0030509 : BMP signaling pathway
- GO:0060070 : canonical Wnt receptor signaling pathway
- GO:0060048 : cardiac muscle contraction
- GO:0003300 : cardiac muscle hypertrophy
- GO:0071313 : cellular response to caffeine
- GO:0005513 : detection of calcium ion
- GO:0003143 : embryonic heart tube morphogenesis
- GO:0008627 : intrinsic apoptotic signaling pathway in response to osmotic stress
- GO:0003220 : left ventricular cardiac muscle tissue morphogenesis
- GO:0010460 : positive regulation of heart rate
- GO:0086094 : positive regulation of ryanodine-sensitive calcium-release channel activity by adrenergic receptor signaling pathway involved in positive regulation of cardiac muscle contraction
- GO:0086029 : Purkinje myocyte to ventricular cardiac muscle cell signaling
- GO:0010881 : regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
- GO:0086005 : regulation of ventricular cardiac muscle cell action potential
- GO:0014808 : release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
- GO:0001666 : response to hypoxia
- GO:0051775 : response to redox state
Source: The Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat. Genet.. May 2000;25(1):25-9.
World Wide Web URL: http://www.geneontology.org/
World Wide Web URL: http://www.geneontology.org/
Disease:
- OMIM:180902 : Ventricular tachycardia, catecholaminergic polymorphic, 1 (OMIM:604772 )
- OMIM:180902 : Arrhythmogenic right ventricular dysplasia 2 (OMIM:600996 )
Source: Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine,
Johns Hopkins University (Baltimore, MD), May, 2012.
World Wide Web URL: http://omim.org/
World Wide Web URL: http://omim.org/
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Screening | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Experimental screening | Non-experimental screening | Reference | ||||||||
TRP channel construct | Interactor source | |||||||||
TRP channel | Interactor | Method | Species | Region | Species | Organ/tissue | Sample type | |||
TRPC3 | RyR2 | Inference | Prediction | 17012351 | ||||||
TRPP1 | RyR2 | Inference | Prediction | 17404231 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Validation: In vitro validation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Assay with recombinant proteins | Reference | |||||||||
TRP channel construct | Interactor construct | |||||||||
TRP channel | Interactor | Method | Species | Region | Expression system | Species | Region | Expression system | ||
TRPP1 | RyR2 | Fusion protein-pull down assay | Human | 1-703 | MDCK lysates | Not used | Mouse cardiac tissue microsome | 17404231 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Validation: In vivo validation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Assay with endogenous proteins | Assay with overexpressed proteins | Reference | ||||||||
Cell or tissue | Cell or tissue | TRP channel construct | Interactor construct | |||||||
TRP channel | Interactor | Method | Species | Region | Species | Region | ||||
TRPC3 | RyR2 | Co-immunofluorescence staining | Rat myocyte section | 17012351 | ||||||
TRPC3 | RyR2 | Co-immunoprecipitation | Rat ventricle lysates | 17012351 | ||||||
TRPP1 | RyR2 | Co-immunoprecipitation | Mouse heart tissue | 17404231 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Characterization | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Binding region mapping | Stoichiometry | Affinity (Kd) | Reference | |||||||
TRP channel | Interactor | |||||||||
TRP channel | Interactor | Method | Species | Region | Species | Region | ||||
TRPP1 | RyR2 | Fusion protein-pull down assay | Human | 703-968 | Mouse | Not determined | 17404231 | |||
TRPP1 | RyR2 | Fusion protein-pull down assay | Human | 130-220 | Mouse | Not determined | 17404231 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)